Wang Y, Wang H, Hu J, Chai J, Luan J, Li J
Nanoscale Adv. 2025; 7(3):711-721.
PMID: 39781242
PMC: 11705069.
DOI: 10.1039/d4na00753k.
Thevenet F, Keshmiri S, Degouttes J, Livingstone J, Lu G, Adam J
Sci Rep. 2025; 15(1):277.
PMID: 39747355
PMC: 11696310.
DOI: 10.1038/s41598-024-80736-0.
Alhaddad L, Osipov A, Leonov S
Int J Mol Sci. 2024; 25(23).
PMID: 39684218
PMC: 11641130.
DOI: 10.3390/ijms252312506.
Guan F, Jiang D, Wang X, Yang M, Iga K, Li Y
ArXiv. 2024; .
PMID: 39314510
PMC: 11419177.
Zink K, Baumann K, Theiss U, Subtil F, Lahrmann S, Eberle F
Health Technol (Berl). 2024; 14(5):929-938.
PMID: 39219555
PMC: 11358185.
DOI: 10.1007/s12553-024-00881-4.
Dose Rate Effects from the 1950s through to the Era of FLASH.
Held K, McNamara A, Daartz J, Bhagwat M, Rothwell B, Schuemann J
Radiat Res. 2024; 202(2):161-176.
PMID: 38954556
PMC: 11426361.
DOI: 10.1667/RADE-24-00024.1.
Novel Combination Treatment for Melanoma: FLASH Radiotherapy and Immunotherapy Delivered by a Radiopaque and Radiation Responsive Hydrogel.
Dong Y, Nieves L, Hsu J, Kumar A, Bouche M, Krishnan U
Chem Mater. 2024; 35(22):9542-9551.
PMID: 38933522
PMC: 11198981.
DOI: 10.1021/acs.chemmater.3c01390.
Democratizing FLASH Radiotherapy.
Moreau M, Mao S, Ngwa U, Yasmin-Karim S, China D, Hooshangnejad H
Semin Radiat Oncol. 2024; 34(3):344-350.
PMID: 38880543
PMC: 11218907.
DOI: 10.1016/j.semradonc.2024.05.001.
Simultaneous dose and dose rate optimization via dose modifying factor modeling for FLASH effective dose.
Ma J, Lin Y, Tang M, Zhu Y, Gan G, Rotondo R
Med Phys. 2024; 51(8):5190-5203.
PMID: 38873848
PMC: 11783338.
DOI: 10.1002/mp.17251.
A comprehensive pre-clinical treatment quality assurance program using unique spot patterns for proton pencil beam scanning FLASH radiotherapy.
Tsai P, Yang Y, Wu M, Chen C, Yu F, Simone 2nd C
J Appl Clin Med Phys. 2024; 25(8):e14400.
PMID: 38831639
PMC: 11302823.
DOI: 10.1002/acm2.14400.
The FLASH effect-an evaluation of preclinical studies of ultra-high dose rate radiotherapy.
McGarrigle J, Long K, Prezado Y
Front Oncol. 2024; 14:1340190.
PMID: 38711846
PMC: 11071325.
DOI: 10.3389/fonc.2024.1340190.
Development and benchmarking of a dose rate engine for raster-scanned FLASH helium ions.
Rank L, Dogan O, Kopp B, Mein S, Verona-Rinati G, Kranzer R
Med Phys. 2023; 51(3):2251-2262.
PMID: 37847027
PMC: 10939952.
DOI: 10.1002/mp.16793.
Ultra-high dose-rate proton FLASH improves tumor control.
Shukla S, Saha T, Rama N, Acharya A, Le T, Bian F
Radiother Oncol. 2023; 186:109741.
PMID: 37315577
PMC: 10527231.
DOI: 10.1016/j.radonc.2023.109741.
Absence of Tissue-Sparing Effects in Partial Proton FLASH Irradiation in Murine Intestine.
Zhang Q, Gerweck L, Cascio E, Gu L, Yang Q, Dong X
Cancers (Basel). 2023; 15(8).
PMID: 37190197
PMC: 10137009.
DOI: 10.3390/cancers15082269.
Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps.
Zou W, Zhang R, Schuler E, Taylor P, Mascia A, Diffenderfer E
Int J Radiat Oncol Biol Phys. 2023; 116(5):1202-1217.
PMID: 37121362
PMC: 10526970.
DOI: 10.1016/j.ijrobp.2023.04.018.
Multi-objective genetic algorithm for synchrotron radiation beamline optimization.
Zhang J, Qi P, Wang J
J Synchrotron Radiat. 2023; 30(Pt 1):51-56.
PMID: 36601925
PMC: 9814073.
DOI: 10.1107/S1600577522010050.
A phenomenological model of proton FLASH oxygen depletion effects depending on tissue vasculature and oxygen supply.
Zou W, Kim H, Diffenderfer E, Carlson D, Koch C, Xiao Y
Front Oncol. 2022; 12:1004121.
PMID: 36518319
PMC: 9742361.
DOI: 10.3389/fonc.2022.1004121.
Ferroptosis, a key to unravel the enigma of the FLASH effect?.
Vilaplana-Lopera N, Abu-Halawa A, Walker E, Kim J, Moon E
Br J Radiol. 2022; 95(1140):20220825.
PMID: 36314903
PMC: 9733624.
DOI: 10.1259/bjr.20220825.
Towards clinical translation of FLASH radiotherapy.
Vozenin M, Bourhis J, Durante M
Nat Rev Clin Oncol. 2022; 19(12):791-803.
PMID: 36303024
DOI: 10.1038/s41571-022-00697-z.
Potential Molecular Mechanisms behind the Ultra-High Dose Rate "FLASH" Effect.
Bogaerts E, Macaeva E, Isebaert S, Haustermans K
Int J Mol Sci. 2022; 23(20).
PMID: 36292961
PMC: 9602825.
DOI: 10.3390/ijms232012109.